Published in Mov Disord on May 15, 2007
Cognitive Behavioral Therapy for Depression in Parkinson's Disease | NCT00810628
Cognitive-behavioral therapy for depression in Parkinson's disease: a randomized, controlled trial. Am J Psychiatry (2011) 1.95
Depression in Parkinson disease--epidemiology, mechanisms and management. Nat Rev Neurol (2011) 1.69
Parkinson's disease: the quintessential neuropsychiatric disorder. Mov Disord (2011) 1.62
Targeting reasoning biases in delusions: a pilot study of the Maudsley Review Training Programme for individuals with persistent, high conviction delusions. J Behav Ther Exp Psychiatry (2011) 1.14
Apathy and depression: separate factors in Parkinson's disease. J Int Neuropsychol Soc (2011) 1.02
CBT for the treatment of depression in Parkinson's disease: a promising nonpharmacological approach. Expert Rev Neurother (2008) 0.99
Telephone-based cognitive-behavioral therapy for depression in Parkinson disease. J Geriatr Psychiatry Neurol (2011) 0.96
Cognitive rehabilitation in Parkinson's disease: evidence from neuroimaging. Front Neurol (2011) 0.94
A meta-analysis of randomised placebo-controlled treatment trials for depression and anxiety in Parkinson's disease. PLoS One (2013) 0.94
Depressive syndromes in neurological disorders. Eur Arch Psychiatry Clin Neurosci (2013) 0.91
A waitlist-controlled trial of group cognitive behavioural therapy for depression and anxiety in Parkinson's disease. BMC Psychiatry (2014) 0.84
The role of cognitive-behavioural therapy for patients with depression in Parkinson's disease. Parkinsons Dis (2011) 0.81
Cognitive Behaviour Therapy for Depression and Anxiety in Parkinson's Disease. J Parkinsons Dis (2015) 0.78
Behavioural interventions for people living with adult-onset primary dystonia: a systematic review. BMC Neurol (2016) 0.77
Palliative care in Parkinson's disease: role of cognitive behavior therapy. Indian J Palliat Care (2009) 0.77
Altered Resting-State Connectivity within Executive Networks after Aneurysmal Subarachnoid Hemorrhage. PLoS One (2015) 0.75
Cognitive-behavioral therapy for depression in Parkinson's disease: a randomized, controlled trial. Am J Psychiatry (2011) 1.95
A program for managing weight gain associated with atypical antipsychotics. Psychiatr Serv (2003) 1.36
Somatic complaints in primary care: further examining the validity of the Patient Health Questionnaire (PHQ-15). Psychosomatics (2006) 1.20
Effectiveness of a time-limited cognitive behavior therapy type intervention among primary care patients with medically unexplained symptoms. Ann Fam Med (2007) 1.15
CBT for the treatment of depression in Parkinson's disease: a promising nonpharmacological approach. Expert Rev Neurother (2008) 0.99
Telephone-based cognitive-behavioral therapy for depression in Parkinson disease. J Geriatr Psychiatry Neurol (2011) 0.96
The impact of antidepressant treatment on cognitive functioning in depressed patients with Parkinson's disease. J Neuropsychiatry Clin Neurosci (2010) 0.91
Neuropsychological outcomes after psychosocial intervention for depression in Parkinson's disease. J Neuropsychiatry Clin Neurosci (2014) 0.89
Escitalopram reduces hot flashes in nondepressed menopausal women: A pilot study. Ann Clin Psychiatry (2009) 0.89
Higher serum caffeine in smokers with schizophrenia compared to smoking controls. Drug Alcohol Depend (2010) 0.87
Predictors of treatment response to cognitive-behavioral therapy for depression in Parkinson's disease. J Consult Clin Psychol (2012) 0.86
The value of pseudoneurological symptoms for assessing psychopathology in primary care. Psychosom Med (2004) 0.86
A cognitive-behavioral treatment package for depression in Parkinson's disease. Psychosomatics (2006) 0.86
Barriers to mental health care utilization in Parkinson's disease. J Geriatr Psychiatry Neurol (2013) 0.85
Depression and sexual functioning in minority women: current status and future directions. J Sex Marital Ther (2005) 0.84
Impulsive smoking in a patient with Parkinson's disease treated with dopamine agonists. J Clin Neurosci (2010) 0.82
Depression in Parkinson's disease: symptom improvement and residual symptoms after acute pharmacologic management. Am J Geriatr Psychiatry (2011) 0.81
Physical symptoms and psychosocial correlates of somatization in pediatric primary care. Clin Pediatr (Phila) (2011) 0.79
Trazodone and ejaculatory inhibition. J Sex Marital Ther (2007) 0.78
Ramelteon for the treatment of insomnia in menopausal women. Menopause Int (2009) 0.78
Efficacy of the team solutions program for educating patients about illness management and treatment. Psychiatr Serv (2006) 0.77
Bupropion improves sexual functioning in depressed minority women: an open-label switch study. J Clin Psychopharmacol (2006) 0.76
Affective-cognitive behavioral therapy for fibromyalgia: a randomized controlled trial. Pain Res Treat (2011) 0.76
STAR*D: the results begin to roll in. Am J Psychiatry (2006) 0.76
Effectiveness research on psychosocial interventions among high-utilising patients in primary care. Evid Based Ment Health (2014) 0.75
Update on the Management of Parkinson's Disease: Focus on Psychosis. Consult Pharm (2016) 0.75
Update on the Management of Parkinson's Disease: Focus on Psychosis. Consult Pharm (2016) 0.75
Treatment of drug dependence in the context of traditional disease treatment models. Psychiatr Serv (2002) 0.75
New directions in the treatment of somatization. Psychiatr Clin North Am (2007) 0.75
Social cognitive complexity and depression: cognitive complexity moderates the correlation between depression self-ratings and global self-evaluation. J Nerv Ment Dis (2002) 0.75